Mohammed S. Taghour

1.5k citations

33 papers · 1.3k indexed · h-index 21

Organic Chemistry top 2%
Molecular Biology top 10%
Toxicology top 0.5%
Oncology
Computational Theory and Mathematics top 5%

Co-authors: Ibrahim H. Eissa Eslam B. Elkaeed Hazem Elkady Ahmed M. Metwaly Hazem A. Mahdy Alaa Elwan Ahmed B. M. Mehany Mohammed A. Dahab
Topics: Synthesis and biological activity (19 papers)Bioactive Compounds and Antitumor Agents (12 papers)Angiogenesis and VEGF in Cancer (12 papers)
Cited by: Toxicology Organic Chemistry Molecular Biology
Journals: PLoS ONE Molecules RSC Advances
Partner nations: Egypt Saudi Arabia United States

In The Last Decade

Mohammed S. Taghour

33 papers receiving 1.3k citations

Peers

Countries citing papers authored by Mohammed S. Taghour

Since Specialization

Citations

This map shows the geographic impact of Mohammed S. Taghour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed S. Taghour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed S. Taghour more than expected).

Fields of papers citing papers by Mohammed S. Taghour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed S. Taghour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed S. Taghour. The network helps show where Mohammed S. Taghour may publish in the future.

Co-authorship network of co-authors of Mohammed S. Taghour

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed S. Taghour. A scholar is included among the top collaborators of Mohammed S. Taghour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed S. Taghour. Mohammed S. Taghour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies 2024 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Hazem Elkady,Hazem A. Mahdy,Mohammed S. Taghour,Mohammed A. Dahab,Alaa Elwan,Mohamed Hagras,(unknown),Ibrahim M. Ibrahim,Dalal Z. Husein,Eslam B. Elkaeed,Aisha A. Alsfouk,Ahmed M. Metwaly,Ibrahim H. Eissa	13
2	New modified thieno[2,3-d]pyrimidine derivatives as VEGFR-2 inhibitors: Design, synthesis, in vitro anti-cancer evaluation and divers in silico studies 2024 ·Journal of Molecular Structure ·Souad A. El‐Metwally,(unknown),Hazem Elkady,Eslam B. Elkaeed,Hanan Al-Ghulikah,Mohammed S. Taghour,Hesham A. El‐Mahdy,Ibrahim M. Ibrahim,Dalal Z. Husein,Ahmed M. Metwaly,Ibrahim H. Eissa	7
3	New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies 2023 ·Computational Biology and Chemistry ·Hazem Elkady,(unknown),(unknown),Mohammed S. Taghour,Mohammed A. Dahab,Hazem A. Mahdy,Alaa Elwan,Hanan Al-Ghulikah,Eslam B. Elkaeed,Ibrahim M. Ibrahim,Dalal Z. Husein,Ahmed M. Metwaly,Ibrahim H. Eissa	16
4	Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2 2023 ·RSC Advances ·Souad A. El‐Metwally,Hazem Elkady,Mohamed Hagras,Dalal Z. Husein,Ibrahim M. Ibrahim,Mohammed S. Taghour,Hesham A. El‐Mahdy,Ahmed Ismail,Bshra A. Alsfouk,Eslam B. Elkaeed,Ahmed M. Metwaly,Ibrahim H. Eissa	15
5	Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors 2023 ·RSC Advances ·Hazem Elkady,(unknown),Alaa Elwan,Mohammed S. Taghour,Hazem A. Mahdy,Mohammed A. Dahab,Eslam B. Elkaeed,Bshra A. Alsfouk,Ibrahim M. Ibrahim,Dalal Z. Husein,E. S. E. Hafez,Amira M.G. Darwish,Ahmed M. Metwaly,Ibrahim H. Eissa	16
6	Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies 2023 ·Journal of Biomolecular Structure and Dynamics ·Mohammed S. Taghour,Hazem Elkady,Wagdy M. Eldehna,Nehal M. El‐Deeb,Ahmed M. Kenawy,(unknown),Eslam B. Elkaeed,Bshra A. Alsfouk,Ahmed M. Metwaly,Ibrahim H. Eissa	41
7	New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations 2023 ·Future Medicinal Chemistry ·Hazem A. Mahdy,Hazem Elkady,Mohammed S. Taghour,Alaa Elwan,Mohammed A. Dahab,Mohamed A. Elkady,Elsayed G.E. Elsakka,Eslam B. Elkaeed,Bshra A. Alsfouk,Ibrahim M. Ibrahim,Ibrahim H. Eissa,Ahmed M. Metwaly	24
8	Discovery of New VEGFR-2 Inhibitors and Apoptosis inducer-based thieno[2,3- d ]pyrimidine 2023 ·Future Medicinal Chemistry ·Souad A. El‐Metwally,Hazem Elkady,Aly F. Mohamed,Eslam B. Elkaeed,Bshra A. Alsfouk,Ahmed S. Doghish,Ibrahim M. Ibrahim,Mohammed S. Taghour,Dalal Z. Husein,Ahmed M. Metwaly,Ibrahim H. Eissa	6
9	Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents 2023 ·RSC Advances ·(unknown),Abdallah E. Abdallah,Hazem Elkady,Ibrahim H. Eissa,Mohammed S. Taghour,(unknown),(unknown),Mohamed Ayman El‐Zahabi	20
10	New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Eslam B. Elkaeed,Mohammed S. Taghour,Hazem A. Mahdy,Wagdy M. Eldehna,Nehal M. El‐Deeb,Ahmed M. Kenawy,Bshra A. Alsfouk,Mohammed A. Dahab,Ahmed M. Metwaly,Ibrahim H. Eissa,Mohamed Ayman El‐Zahabi	58
11	Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation 2022 ·Molecules ·Alaa Elwan,Abdallah E. Abdallah,Hazem A. Mahdy,Mohammed A. Dahab,Mohammed S. Taghour,Eslam B. Elkaeed,Ahmed B. M. Mehany,(unknown),(unknown),Aisha A. Alsfouk,Hazem Elkady,Ibrahim H. Eissa	51
12	Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway 2022 ·PLoS ONE ·Mohammed S. Taghour,Hazem Elkady,Wagdy M. Eldehna,Nehal M. El‐Deeb,Ahmed M. Kenawy,Eslam B. Elkaeed,Bshra A. Alsfouk,Mohamed S. Alesawy,Dalal Z. Husein,Ahmed M. Metwaly,Ibrahim H. Eissa	40
13	Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed S. Taghour,Hazem A. Mahdy,(unknown),(unknown),(unknown),Alaa Elwan,Mohammed A. Dahab,Eslam B. Elkaeed,Aisha A. Alsfouk,Mohamed M. Khalifa,Ibrahim H. Eissa,Hazem Elkady	43
14	In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) 2021 ·Molecules ·Mohamed S. Alesawy,Abdallah E. Abdallah,Mohammed S. Taghour,Eslam B. Elkaeed,Ibrahim H. Eissa,Ahmed M. Metwaly	53
15	Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Nawaf A. Alsaif,Mohammed S. Taghour,Mohammed M. Alanazi,Ahmad J. Obaidullah,Abdulrahman A. Almehizia,(unknown),(unknown),Alaa Elwan,Hazem Elkady	57
16	Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed M. Alanazi,Alaa Elwan,Nawaf A. Alsaif,Ahmad J. Obaidullah,Hamad M. Alkahtani,Abdulrahman A. Almehizia,(unknown),Mohammed S. Taghour,Ibrahim H. Eissa	45
17	Targeting VEGFR‐2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies 2021 ·Archiv der Pharmazie ·Nawaf A. Alsaif,Hazem A. Mahdy,Mohammed M. Alanazi,Ahmad J. Obaidullah,Hamad M. Alkahtani,(unknown),(unknown),Alaa Elwan,Mohammed S. Taghour	21
18	Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies 2021 ·Bioorganic & Medicinal Chemistry ·Nawaf A. Alsaif,Mohammed S. Taghour,Mohammed M. Alanazi,Ahmad J. Obaidullah,Wael A. Alanazi,Abdullah F. Alasmari,(unknown),Mohammed A. Dahab,Hazem A. Mahdy	32
19	New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies 2021 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Hazem Elkady,Alaa Elwan,Hesham A. El‐Mahdy,Ahmed S. Doghish,Ahmed Ismail,Mohammed S. Taghour,Eslam B. Elkaeed,Ibrahim H. Eissa,Mohammed A. Dahab,Hazem A. Mahdy,Mohamed M. Khalifa	112
20	Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors 2018 ·European Journal of Medicinal Chemistry ·M.K. Ibrahim,Mohammed S. Taghour,Ahmed M. Metwaly,Amany Belal,Ahmed B. M. Mehany,Mostafa A. Elhendawy,Mohamed M. Radwan,Abdelrahman M. Yassin,Nehal M. El‐Deeb,E. S. E. Hafez,Mahmoud A. ElSohly,Ibrahim H. Eissa	109

About Mohammed S. Taghour

Mohammed S. Taghour is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Synthesis and biological activity (19 papers), Bioactive Compounds and Antitumor Agents (12 papers) and Angiogenesis and VEGF in Cancer (12 papers). The work is most often cited by research in Toxicology (246 citations), Organic Chemistry (911 citations) and Molecular Biology (701 citations). Mohammed S. Taghour has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Ibrahim H. Eissa, Eslam B. Elkaeed, Hazem Elkady, Ahmed M. Metwaly, Hazem A. Mahdy, Alaa Elwan, Ahmed B. M. Mehany, Mohammed A. Dahab, Nehal M. El‐Deeb and Mohamed S. Alesawy. Their work appears in journals such as PLoS ONE, Molecules and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact